Recurrence of Helicobacter pylori Infection after Successful Eradication Therapy in Egyptian Patients

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Acta scientific gastrointestinal disorders Acta scientific international open library Volume:
Keywords : Recurrence , Helicobacter pylori Infection after Successful    
Abstract:
Background: Helicobacter pylori (H. pylori), a highly prevalent gastrointestinal organism, infects more than 50% of the global population. It is the most common risk factor for peptic ulcer disease, cancer stomach and gastric lymphoma. Eradication therapy regimens for H. pylori are highly effective. However, bacterial resistance to antibiotics and patients non￾adherence to the treatment regimens significantly increased the recurrence rates of H. pylori infection in the last few decades. Patients and Methods: We evaluated and followed up 157 patients for one year after confirmed successful eradication of H. pylori infection. We investigated the patients at 3, 6, 9 and 12 months for recurrence of H. pylori infection using urea breath and stool antigen tests. Study Aim: To assess the prevalence and possible risk factors of H. pylori recurrence in Egyptian patients after eradication therapy. Results and Conclusion: We found a one-year recurrence rate of 19% after successful eradication therapy of H. pylori. The education level of the patients and alcohol consumption were the most significant predictors of H. pylori recurrence. The one-year recurrence rate in our study is high but comparable to those reported in the developing countries most probably due to high rates of re-infection and non-adherence to the preventive measures
   
     
 
       

Author Related Publications

  • Mohammed Ahmed Ali Bassiouni, "Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients", Wolters Kluwer Health, Inc., 2017 More
  • Mohammed Ahmed Ali Bassiouni, "Lipocalin-2: A novel diagnostic marker for hepatocellular carcinoma", IOS press, 2020 More
  • Mohammed Ahmed Ali Bassiouni, "Management of HCV‑related decompensated cirrhosis with direct‑acting antiviral agents: who should be treated?", Springer, 2019 More
  • Mohammed Ahmed Ali Bassiouni, "Prevalence and Risk Factors of Minimal Hepatic Encephalopathy in Patients with Compensated Liver Cirrhosis", Ain Shams University, 2020 More
  • Mohammed Ahmed Ali Bassiouni, "Clinical Outcomes of Upper Gastrointestinal Bleeding in Egyptian Patients with Decompensated Liver Cirrhosis, Does the Bleeding Source Matter?", Ain Shams University, 2020 More

Department Related Publications

  • Ahmed Adel Hassan Muhamad, "دراسة سريرية مرضية لالتهاب الكبد الهلالى المتكاثر عند الاطفال", لايوجد, 1900 More
  • Ahmed Adel Hassan Muhamad, "ثبات وظائف الكلى المزروعة فى المستقبلون للكلى ويعالجون بعقار السانداميسون متابعة طويلة المدى", لايوجد, 1900 More
  • Ahmed Adel Hassan Muhamad, "دراسة الاجسام المضادة لمضادات الكارديولابيبين ومتلازمة الكارديولابيبين فى مرضى الروماتويد المفصلى", لايوجد, 1900 More
  • Ahmed Adel Hassan Muhamad, "الاجسام المضادة السامة للخلايا الليمفاوية للزوج فى حالات ارتفاع ضغط الدم المصاحب للحمل", لايوجد, 1900 More
  • Ahmed Adel Hassan Muhamad, "تأثير من انظمة التثبيط المناعى على انتاج مادة عوامل النمو المحولtof-B1 فى متلقى زرع الكلى", لايوجد, 1900 More
Tweet